SCHEMBL10847336

SCHEMBL10847336

CCCCCCCCCCCCCCCC(O)COP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.67
▸ AKT1 P31749 2/20 0.67
▸ ESR1 P03372 1/20 0.67
▸ ADORA3 P0DMS8 1/20 0.67
▸ CDC25A P30304 1/20 0.67
▸ AGTR1 P30556 1/20 0.67
▸ ADRA1A P35348 1/20 0.67
▸ KCNH2 Q12809 1/20 0.67
▸ SMN1; SMN2 Q16637 3/20 0.66
▸ MEN1 O00255 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ PRKD3 O94806 1/20 0.63
▸ PRKCG P05129 1/20 0.63
▸ PRKCB P05771 1/20 0.63
▸ PRKCA P17252 1/20 0.63
▸ PRKCH P24723 1/20 0.63
▸ PRKCI P41743 1/20 0.63
▸ PRKCE Q02156 1/20 0.63
▸ PRKCQ Q04759 1/20 0.63
▸ PRKCZ Q05513 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10845546 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10847557 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10847240 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10850808 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10847101 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10848422 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10846398 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10846278 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10847452 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL10845565 1.00 LMNA (0.67) LMNAAKT1ESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4610979-A O-acyl-alkanediol-phospholipids and processes for the treatment of asthma A. NATTERMANN & CIE GMBH (DE) 1986-09-09 — — US disclosed
Send feedback